| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | -9.41% | +0.21% | -9.62% | -9.62% | — |
| 14d | 1 | +0.00% | -12.38% | -1.35% | -11.03% | -11.03% | — |
| 30d | 1 | +0.00% | -10.40% | +0.32% | -10.72% | -10.72% | — |
| 60d | 1 | +0.00% | -14.11% | +4.78% | -18.89% | -18.89% | — |
| 90d | 1 | +0.00% | -20.30% | +5.42% | -25.72% | -25.72% | — |
| 180d | 1 | +0.00% | -10.40% | +9.65% | -20.05% | -20.05% | — |
| 1y | 1 | +0.00% | -33.91% | +15.41% | -49.33% | -49.33% | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jun 10, 2026 | Jun 11, 2026 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Apr 1, 2025 | Apr 2, 2025 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASE | 5,000 | $3.96 | $19.8K | 5,014 | Aug 19, 2024 | Aug 19, 2024 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 1,778 | — | — | 1,778 | Jul 1, 2024 | Jul 3, 2024 ↗ | View → |
| SKYE SKYE BIOSCIENCE, INC. | PURCHASEGRANT Stock grant | 35,000 | — | — | 35,000 | Feb 29, 2024 | Mar 4, 2024 ↗ | View → |
| SKYE SKYE BIOSCIENCE, INC. | PURCHASEGRANT Stock grant | 14,110 | — | — | 20,001 | Nov 6, 2023 | Nov 6, 2023 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 5,000 | — | — | 5,000 | Sep 29, 2023 | Oct 3, 2023 ↗ | View → |
| SKYE SKYE BIOSCIENCE, INC. | PURCHASEGRANT Stock grant | 1,472,692 | — | — | 1,472,692 | Aug 25, 2023 | Aug 29, 2023 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 8,000 | — | — | 8,000 | Mar 3, 2023 | Mar 8, 2023 ↗ | View → |
| SKYE SKYE BIOSCIENCE, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Jan 5, 2023 | Jan 5, 2023 ↗ | View → |
| SKYE SKYE BIOSCIENCE, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Jan 5, 2023 | Jan 9, 2023 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 5,000 | — | — | 5,000 | Feb 1, 2022 | Feb 3, 2022 ↗ | View → |
| SKYE SKYE BIOSCIENCE, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 275,000 | Sep 14, 2021 | Sep 16, 2021 ↗ | View → |
| SKYE SKYE BIOSCIENCE, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Jul 22, 2021 | Jul 26, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP, R&D | 28,690 | — | — | 137,351 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP, R&D | 2,990 | — | — | 72,334 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP, R&D | 28,690 | — | — | 57,380 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP, R&D | 9,727 | — | — | 82,061 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP, R&D | 26,600 | — | — | 26,600 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP, R&D | 2,990 | — | — | 0 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP, R&D | 9,727 | — | — | 0 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP, R&D | 16,560 | $7.19 | $119.1K | 120,791 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP, R&D | 26,600 | — | — | 108,661 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 32,100 | — | — | 32,100 | Feb 11, 2021 | Feb 16, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 96,310 | — | — | 96,310 | Feb 11, 2021 | Feb 16, 2021 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP, R&D | 4,844 | $1.96 | $9.5K | 69,344 | Apr 22, 2020 | Apr 24, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 19,893 | — | — | 74,188 | Apr 22, 2020 | Apr 24, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP, R&D | 9,726 | — | — | 27,695 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP, R&D | 2,990 | — | — | 2,990 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP, R&D | 9,726 | — | — | 9,727 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP, R&D | 2,990 | — | — | 17,969 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP, R&D | 26,600 | — | — | 53,200 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP, R&D | 26,600 | — | — | 54,295 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 86,070 | — | — | 86,070 | Feb 6, 2020 | Feb 10, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 258,210 | — | — | 258,210 | Feb 6, 2020 | Feb 10, 2020 ↗ | View → |